Inhibiting NF-κB activation by small molecules as a therapeutic strategy.
Inhibiting NF-κB activation by small molecules as a therapeutic strategy.
复制标题
通过小分子抑制 NF-κB 激活作为治疗策略。
DOI:
10.1016/j.bbagrm.2010.05.004
复制
发表时间:
2010-10
影响因子:
4.7
通讯作者:
Aggarwal, Bharat B.
中科院分区:
文献类型:
--
作者:
Gupta, Subash C.;Sundaram, Chitra;Reuter, Simone;Aggarwal, Bharat B.
Because nuclear factor-κB (NF-κB) is a ubiquitously expressed proinflammatory transcription factor that regulates the expression of over 500 genes involved in cellular transformation, survival, proliferation, invasion, angiogenesis, metastasis, and inflammation, the NF-κB signaling pathway has become a potential target for pharmacological intervention. A wide variety of agents can activate NF-κB through canonical and noncanonical pathways. Canonical pathway involves various steps including the phosphorylation, ubiquitnation, and degradation of the inhibitor of NF-κB (IκBα), which leads to the nuclear translocation of the p50- p65 subunits of NF-κB followed by p65 phosphorylation, acetylation and methylation, DNA binding, and gene transcription. Thus, agents that can inhibit protein kinases, protein phosphatases, proteasomes, ubiquitnation, acetylation, methylation, and DNA binding steps have been identified as NF-κB inhibitors. Here, we review the small molecules that suppress NF-κB activation and thus may have therapeutic potential.
登录
查看更多内容
影响因子:
30.5
作者:
Arbibe, Laurence;Kim, Dong Wook;Sansonetti, Philippe J.
通讯作者:
Sansonetti, Philippe J.
影响因子:
64.8
作者:
Belich, MP;Salmerón, A;Ley, SC
通讯作者:
Ley, SC
影响因子:
4.8
作者:
Chang, NS
通讯作者:
Chang, NS
影响因子:
8
作者:
Bernard, D;Monte, D;Abbadie, C
通讯作者:
Abbadie, C
影响因子:
5.2
作者:
Choi, Kyung-Chul;Lee, Yoo-Hyun;Yoon, Ho-Geun
通讯作者:
Yoon, Ho-Geun